LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Liabilities, Other
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Deferred Tax Liabilities, Other of $2.11 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilitiesOther · last filed 2026-02-27
- 2025-12-31: Deferred Tax Liabilities, Other $2.11M.
- 2024-12-31: Deferred Tax Liabilities, Other $3.99M.
- 2023-12-31: Deferred Tax Liabilities, Other $10.50M.
- 2022-12-31: Deferred Tax Liabilities, Other $10.89M.
| Period end | Deferred Tax Liabilities, Other | Deferred Tax Liabilities, Other as first filed |
|---|---|---|
| 2025-12-31 | $2.11M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $3.99M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $10.50M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $10.89M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $5.46M 10-K · filed 2023-02-28 | $9.30M 10-K · filed 2022-02-28 |
| 2020-12-31 | $4.92M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $10.94M 10-K · filed 2021-02-24 | $964.00K 10-K · filed 2020-02-27 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |